LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Secured Loans History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Secured Loans | ₹9.72 Cr | ₹7.18 Cr | ₹0.39 Cr | ₹0.86 Cr | ₹151 Cr |
What is the latest Secured Loans ratio of LYKA LABS ?
| Year | Secured Loans |
|---|---|
| Mar2025 | ₹9.72 Cr |
| Mar2024 | ₹7.18 Cr |
| Mar2023 | ₹0.39 Cr |
| Mar2022 | ₹0.86 Cr |
| Mar2021 | ₹151 Cr |
How is Secured Loans of LYKA LABS Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.72 Cr | 35.48 | |
| Mar2024 | ₹7.18 Cr | 1,759.07 | |
| Mar2023 | ₹0.39 Cr | -55.06 | |
| Mar2022 | ₹0.86 Cr | -99.43 | |
| Mar2021 | ₹151 Cr | - | |
Compare Secured Loans of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹207.5 Cr | 7.5% | 0.5% | -45.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 7.5% |
0.5% |
-45.6% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses